CHIRINO, A.J. ET AL.: 'Minimizing the immunogenicity of protein therapeutics.' DRUG DISCOVERY TODAY vol. 9, no. 2, 2004, pages 82 - 90, XP002395255 (B1)

EP-A1- 2 194 066 (B1)

EP-A1- 2 202 245 (B1)

EP-A1- 2 206 775 (B1)

EP-A1- 2 275 443 (B1)

YOSHIYUKI OSUGI: 'Kotai Iyakuhin no Genzai Shinkokei -Kaihatsu.Seisan Gijutsu.Tokkyo Han'i- Seizo Hanbai Shonin o Eta Kaihatsu Hinmoku no Success Story Nipponhatsu Saisho no Kotai Iyaku 'Hito-ka Ko-hito-interleukin-6 Juyotai Kotai (Tocilizumab)' no Kenkyu Kaihatsu Keii -Kiso Kenkyu, Tansaku Kenkyu kara Soyaku Kenkyu,' GEKKAN PHARM STAGE vol. 7, no. 5, 2007, pages 13 - 18, XP008143206 (B1)

JP-A- 2 163 096 (B1)

ONDA, M. ET AL.: 'Lowering the Isoelectric Point of the Fv Portion of Recombinant Immunotoxins Leads to Decreased Nonspecific Animal Toxicity without Affecting Antitumor Activity.' CANCER RES. vol. 61, 2001, pages 5070 - 5077, XP002359466 (B1)

RAJPAL, A. ET AL.: 'A general method for greatly improving the affinity of antibodies by using combinatorial libraries.' PROC.NATL.ACAD.SCI.USA vol. 102, no. 24, 2005, pages 8466 - 8471, XP002392777 (B1)

WO-A2-2007/143168 (B1)

ITO, W. ET AL.: 'The His-probe method: effects of histidine residues introduced into the complementary-determining regions of antibodies on antigen-antibody interactions at different pH values.' FEBS LETT. vol. 309, no. 1, 1992, pages 85 - 88, XP008123385 (B1)